EXO1 and lung cancer: As shown in Figures 3(a)–3(c), two cohorts of LUAD of lung cancer revealed that higher expression of EXO1 had poorer impact on the PFS and OS (P = 0.0033; P = 0.0026); however, LUSC had no impact on prognosis (Figures 3(b)–3(d)).